Accelerated approvals hit the target in precision oncology

被引：0
|
作者：
Vivek Subbiah
Lori J. Wirth
Razelle Kurzrock
Richard Pazdur
Julia A. Beaver
Harpreet Singh
Gautam U. Mehta
机构：
[1] The University of Texas MD Anderson Cancer Center,Harvard Medical School
[2] Massachusetts General Hospital,Oncology Center of Excellence
[3] Medical College of Wisconsin Cancer Center and Genome Science and Precision Medicine Center,Center for Drug Evaluation and Research
[4] US Food and Drug Administration,undefined
[5] US Food and Drug Administration,undefined
来源：
Nature Medicine | 2022年 / 28卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1976 / 1979
页数：3
相关论文
共 50 条
  • [1] Accelerated approvals hit the target in precision oncology
    Subbiah, Vivek
    Wirth, Lori J.
    Kurzrock, Razelle
    Pazdur, Richard
    Beaver, Julia A.
    Singh, Harpreet
    Mehta, Gautam U.
    NATURE MEDICINE, 2022, 28 (10) : 1976 - 1979
  • [2] "Dangling" Accelerated Approvals in Oncology
    Beaver, Julia A.
    Pazdur, Richard
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (18):
  • [3] Accelerated drug approvals in oncology: Pros and cons
    Thakur, Sayanta
    Lahiry, Sandeep
    INDIAN JOURNAL OF CANCER, 2021, 58 (01) : 114 - 118
  • [4] Lessons from withdrawn accelerated approvals in oncology
    George S. Mellgard
    Tito Fojo
    Susan E. Bates
    Nature Cancer, 2024, 5 : 211 - 215
  • [5] Lessons from withdrawn accelerated approvals in oncology
    Mellgard, George S.
    Fojo, Tito
    Bates, Susan E.
    NATURE CANCER, 2024, 5 (2) : 211 - 215
  • [6] Precision Oncology: Approaching the Target
    Hiddemann, Wolfgang
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2017, 142 (22) : 1637 - 1637
  • [7] Oncology's trial and error: Analysis of the FDA withdrawn accelerated approvals
    Preziosi, Anthony J.
    Priefer, Ronny
    LIFE SCIENCES, 2024, 346
  • [8] ARE FDA ACCELERATED APPROVALS UNCONDITIONAL APPROVALS?
    Macaulay, R.
    Tsang, R.
    VALUE IN HEALTH, 2018, 21 : S94 - S94
  • [9] Accelerated approvals examined
    Emma Dorey
    Nature Biotechnology, 2011, 29 (3) : 176 - 176
  • [10] Approvals in 2021: dangling Accelerated Approvals, drug dosing, new approvals and beyond
    Lemery, Steven
    Pazdur, Richard
    NATURE REVIEWS CLINICAL ONCOLOGY, 2022, 19 (04) : 217 - 218
12345